Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Study on the Management of Hematological Toxicities Associated With Targeted Therapies for Breast Cancer

NCT06503380 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT06503380
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06503380 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Study on the Management of Hematological Toxicities Associated With Targeted Therapies for Breast Cancer
Lead sponsor
Fudan University
Phase
Observational
Overall status
Recruiting
Start date
July 15, 2024
Completion date
June 10, 2027
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, hematological toxicity, targeted therapy